Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged the market over the trailing-12-month period. That said, there are good reasons to expect both to bounce back and perform well over the long run.
But which is a better stock to invest in today? Let's find out.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Aktie
31,00 €
1,64 %
Eine klare Tendenz zu Buy-Einschätzungen bei Viking Therapeutics Inc, ohne Sell-Einschätzungen.
Das Kursziel von 50 € für Viking Therapeutics Inc impliziert eine deutliche Steigerung um über 50% gegenüber 31.0 €.
